En
En

Digital transformation for life sciences

 

from drug discovery to pharmaceutical manufacturing

Download the whitepaper
avenga.com

The next normal

 

The next normal has already arrived. It is shaped by a whole range of factors and new global experiences that are sparking waves of innovation. Examples are a tremendous growth of digitization, from IoT for remote patient monitoring to evolutionary algorithms for drug development, is pervading deeper into all the phases of the drug development life cycle.

Learn how digital technology:

 

  • accelerates drug discovery
  • streamlines clinical trials
  • augments pharmaceutical manufacturing and distribution
  • eases up drug commercialization processes
  • improves drug safety
  • simplifies pharmacovigilance and adverse event reporting

Avenga-Whitepaper-Mockup-Life-Sciences-1

 

Quick stats on technology shaping pharma

1000
times faster compound screening using high-throughput screening
 
Source: PubMed Central
76%
of patients prefer to participate in a mobile clinical trial over a traditional one
 
Source: CTTI
80%
faster decision-making, thanks to the workforce enablement of wearables and data from them
 
Source: Kranz, Maciej

Value of digital transformation in the pharmaceutical industry

 

Only 1 in 10 medications that enter the clinical trial phase actually reach the market. Can drug development processes be improved? What are the possible solutions? Regardless of at which stage of drug development you are, in this whitepaper, you'll find technology solutions for various stages of the pharmaceutical lifecycle:

 

5 technology solutions to augment drug discovery

  1. Predict the behavior of chemical compounds in potential drugs and their pharmaceutical ADME (absorption, distribution, metabolism, and excretion) properties using neural networks for drug discovery.

  2. Identify molecules that are synthesizable, stable and refined for multiple criteria with the help of genetic programming and evolutionary algorithms.

  3. Collect, consolidate, structure and extract valuable entities from unstructured data. Find medications that can treat COVID-19 using knowledge graphs. 

  4. Determine prospective target molecules from millions of candidate compounds. Improve the outcomes and quality of the compound analysis using high-throughput screening. 

  5. Store data from virtual compound screening on cloud services, while scaling up and down to address the computational demands. 

6 technology solutions to empower clinical trials

  1. Identify influential principal investigators who can empower clinical trials by recruiting eligible patients using natural language processing (NLP) for patient enrollment. 

  2. Predict patient outcomes from electronic health records (EHRs) using NLP, machine learning and recurrent neural networks.

  3. Obtain data-driven definitions of diseases using computational disease phenotyping.

  4. Revolutionize real-time monitoring of diseases by collecting essential data, like heart rate, glucose levels, movement disorders, concussions and other medical events using wearables and IoT for remote patient monitoring. 

  5. Transcribe patient visits using voice assistants for ultimate precision. 

  6. Enhance the quality and efficacy of clinical trials, enlarge the scale and reach, decrease the patient’s burden, and improve engagement with virtual and decentralized clinical trial implementation.

3 ways to improve pharmaceutical manufacturing and distribution

  1. Reenergize a traditional distribution value chain, enabling mass customization and a real-time information exchange between buyers and manufacturers using IoT for drug asset management.

  2. Anticipate the possible breakdown of machines and equipment using predictive maintenance systems for pharma manufacturing.

  3. Ensure the pharmaceutical production line has no defects and that customers enjoy seamless treatments with quality assurance practices.

2 ways to ignite drug commercialization

  1. Better organize the collaboration between pharmaceutical customer representatives and doctors using Salesforce CRM. 

  2. Consolidate marketing workflows into unified multi-channel marketing automation systems and ensure there are no gaps in marketing and sales activities.

3 technology solutions to simplify pharmacovigilance

  1. Exclude noise-induced adverse drug events as well as aggregate and systematize adverse event reports from different sources and channels using deep learning techniques.

  2. Structure unlabeled electronic health records (EHR) data, make it easily searchable and obtain insights, using natural language processing (NLP).

  3. Implement a well-thought out data management strategy and ensure elaborate data validation policies with data governance.
Read more in the whitepaper

Download the whitepaper
close

About Avenga

 

Reasons why you should consider partnering with us: 

  • Having 20 years of experience as a technology partner, we bridge together domain knowledge and capabilities, enabling our pharmaceutical clients to get technologically fit and stay ahead of the competition. 

  • Being a truly global consultancy (not just sales guys around the globe like many competitors have); with delivery centers in Germany, Poland, Ukraine, and Malaysia along with a sales office in the United States. Our optimal blend of delivery locations allow us to make unique proposals in terms of price, offered value, proximity and compliance.

  • Operating in our in-house R&D center, we work tirelessly to produce effective technological solutions and viable results for our clients. 

  • Providing rapid scalability, thanks to efficient recruitment processes. We can extend your team with the right tech talent either for short term or long term, in addition to upscaling or downscaling your team whenever needed.

  • Offering flexibility via various engagement models, such as time and material, fixed prices, and dedicated teams. 

  • We are a Salesforce Silver partner, Microsoft Gold partner, Xamarin premier consulting partner, and one of the Top 100 Global Outsourcing companies as selected by IAOP and Fortune.
quote_red

Affordability and depth of expertise have made them a critical development partner. Their team easily scales to accommodate project size and is equally flexible with scheduling across time zones.

Suhail Mughal,
CTO, QPharma
quote_red

 Their team provided staff augmentation for a software development house. They used a mix of technologies in order to fully integrate into existing scrum teams. Their staff were consistently ranked as top performers on their teams. The ability to adapt to project specifications was a hallmark of their work, and contributed to the recent expansion of their role.

Mick Davison
VP of Software Development, Instem
quote_red

Nothing was too complicated for them, and everything about their process is straightforward. A week after launch, there was visible platform growth, while deployment requests increased by 50%. They established a good rapport with the internal team and was communicative and easy to work with.

Stephen Milner
CEO, AMMI Systems

Trusted by

 

top-clients-mobile-1

 

Have any questions? Ask us

 

More

© 2022 Avenga. All rights reserved.